COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,010 Articles (22,627 medRxiv, 8,383 bioRxiv)

Most recent first Previous |  Page 1603: Articles 16021-16030  | Next

Incidence of Long-term Post-acute Sequelae of SARS-CoV-2 Infection Related to Pain and Other Symptoms: A Living Systematic Review and Meta-analysis
Hoshijima, H., Mihara, T., Seki, H., Hyuga, S., Kuratani, N., Shiga, T.
10.1101/2021.04.08.21255109 — Posted: 2021-04-11
Accuracy of antigen and nucleic acid amplification testing on saliva and naopharyngeal samples for detection of SARS-CoV-2 in ambulatory care
Kerneis, S., Elie, C., Fourgeaud, J., Choupeaux, L., Mercier Delarue, S., Alby, M. L., Quentin, P., Pavie, J., Brazille, P., Nere, M. L., Minier, M., Gabassi, A., Gibaud, A., Gauthier, S., Leroy, C., Voirin Mathieu, E., Poyart, C., Vidaud, M., Parfait, B., Delaugerre, C., Treluyer, J. M., Le Goff, J.
10.1101/2021.04.08.21255144 — Posted: 2021-04-11
Emergence of multiple SARS-CoV-2 antibody escape variants in an immunocompromised host undergoing convalescent plasma treatment
Chen, L., Zody, M. C., Mediavilla, J. R., Cunningham, M. H., Composto, K., Chow, K. F., Kordalewska, M., Corvelo, A., Oschwald, D. M., Fennessey, S., Zetkulic, M., Dar, S., Kramer, Y., Mathema, B., Maniatis, T., Perlin, D. S., Kreiswirth, B. N.
10.1101/2021.04.08.21254791 — Posted: 2021-04-11
Development of a tool to prioritize the monitoring of COVID-19 patients by public health teams
Vecino-Ortiz, A. I., Guzman-Tordecilla, N., Guzman Ruiz, Y. F., Penaloza-Quintero, R. E., Fernandez-Nino, J. A., Ruiz Gomez, F., Trujillo, A. J.
10.1101/2021.04.08.21254922 — Posted: 2021-04-11
Changing patterns of sickness absence among healthcare workers in England during the COVID-19 pandemic.
Edge, R., van der Plaat, D. A., Parsons, V., Coggon, D., van Tongeren, M. J., Muiry, R., Madan, I., Cullinan, P.
10.1101/2021.04.08.21255128 — Posted: 2021-04-10
Estimating COVID-19 infection fatality rate in Mumbai during 2020
Banaji, M.
10.1101/2021.04.08.21255101 — Posted: 2021-04-10
Early evidence of COVID-19 vaccine effectiveness within the general population of California
Andrejko, K., Pry, J. M., Myers, J. F., Jewell, N. P., Openshaw, J., Watt, J., Jain, S., Lewnard, J. A.
10.1101/2021.04.08.21255135 — Posted: 2021-04-10
Real-world Effect of Monoclonal Antibody Treatment in COVID-19 Patients in a Diverse Population in the United States
Rainwater-Lovett, K., Redd, J. T., Stewart, M. A., Elias Calles, N., Cluff, T., Fang, M., Panaggio, M. J., Lambrou, A. S., Thornhill, J. K., Bradburne, C., Imbriale, S., Freeman, J. D., Anderson, M., Kadlec, R. P.
10.1101/2021.04.08.21254705 — Posted: 2021-04-10
Convalescent Plasma Use in the United States was inversely correlated with COVID-19 Mortality: Did Convalescent Plasma Hesitancy cost lives?
Casadevall, A., Dragotakes, Q., Johnson, P. W., Senefeld, J. W., Klassen, S. S., Wright, S. R., Joyner, M. J., Paneth, N., Carter, R.
10.1101/2021.04.07.21255089 — Posted: 2021-04-10
Modelling the impact of extending dose intervals for COVID-19 vaccines in Canada
Nam, A., Ximenes, R., Yeung, M. W., Mishra, S., Wu, J., Tunis, M., Sander, B.
10.1101/2021.04.07.21255094 — Posted: 2021-04-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).